Infex partners with Alderley Analytical to provide PK and ADA analysis for RESP-X program
Alderley Park, Cheshire Infex Therapeutics has today announced a deal with…
Introducing Infex Therapeutics
The organisation leading UK efforts to tackle the health crisis around our…
Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award
The AMR Centre has combined forces to attract much needed investment to…
More People in the United States Dying from Antibiotic-Resistant Infections than Previously Estimated
Significant progress since 2013 could be lost without more action The…
AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes
Alderley Park, UK The AMR Centre has nominated a preclinical candidate in…
The AMR Centre set for partnership with Shionogi for new superbug therapy
The AMR Centre Ltd has today announced a landmark agreement with the Japanese…
AMR Centre to join first life sciences delegation to Biomed in Israel
The North’s life sciences landscape will be showcased on an international…
The AMR Centre secures £2.3m funding boost
The AMR Centre, a body with public and private investors leading the UK’s…
